No Image Available

Superficial vein

ClosureFast™ radiofrequency ablation (RFA) system

<p>The ClosureFast™ procedure uses radiofrequency energy to treat patients with superficial vein disease.</p>



Explore the ClosureFast™ RFA system.

Technology you know and trust

Gap-free thermal ablation

The ClosureFast™ RFA system delivers uniform heat for lasting vein closure.1

  • Patented segmental procedure
  • Less pain and bruising than laser energy treatment2
  • Proven clinical results and rapid patient recovery1,2

 

Data are from ClosureFast™ 7 Fr studies. ClosureFast™ 6 Fr catheter is designed to provide the same outcomes as established by ClosureFast™ 7 Fr catheter.

View a woman stretching her leg outside while running.

Catheter inserted
into vein

This is an image of the catheter that is inserted in a vein during the ClosureFast™ radiofrequency ablation procedure.

Controlled heat
collapses vein

This is an image of the ClosureFast™ radiofrequency ablation catheter collapsing a vein with heat.

Catheter withdrawn,
closing vein

This is an image of the ClosureFast™ radiofrequency ablation catheter being withdrawn from a vein as it collapses after heat treatment.

Proven procedure, lower profile

The ClosureFast™ radiofrequency ablation catheter is now available in 6F, designed for†,‡:

  • Enhanced flexibility
  • Improved navigation
  • Increased kink resistance
     

† Compared to ClosureFast™ 7 Fr catheter and Venclose™* catheter in bench testing.

‡ Bench test data on file at Medtronic. N = 15 Venclose™* catheters and 30 each ClosureFast™ 6 Fr and 7 Fr catheters. Bench tests may not be indicative of clinical performance.


Deliver lasting results with gap-free thermal ablation.

The ClosureFast™ procedure features a patented overlap of 0.5 cm at each thermal treatment segment, eliminating gaps between segments ― for lasting vein closure.1,3

6F profile, 8 cm heating length

This is an illustration of a catheter showing an overlap of 0.5 cm at each thermal treatment segment during the ClosureFast™ radiofrequency ablation procedure.

1. 8 cm ablation

2. 0.5 cm overlap

3. 8 cm ablation

Note: 3 cm (7F) heating length available for shorter segments.


Clinical evidence

  • 72% improvement in VCSS scores at 5 years4
  • 91.9% closure at 5 years1
  • 94.9% reflux-free rate at 5 years1
  • 3M+ patients treated5
  • 200+ published articles and clinical studies6
  • 2006: U.S. FDA clearance 7F catheter

Data are from ClosureFast™ 7F studies. ClosureFast™ 6F catheter is designed to provide the same outcomes as established by ClosureFast™ 7F catheter.



Indications

The ClosureFast™ radiofrequency ablation catheter is intended for endovascular coagulation of blood vessels in patients with superficial vein reflux.


System components


ClosureFast™ radiofrequency ablation catheter

  • The ClosureFast™ radiofrequency ablation catheter precisely heats an 8 cm vein segment (or 3 cm for shorter, refluxing vein lengths) in one 20-second interval.
  • The heat provided by the catheter shrinks and collapses the target vein, creating a fibrotic seal and occluding the vessel.
This is an image of the ClosureFast™ endovenous radiofrequency ablation catheter.

ClosureFast™ radiofrequency stylet

  • The ClosureRFS™ radiofrequency stylet is an intravascular ablation device specifically intended for the treatment of incompetent perforator and tributary veins.
  • This minimally invasive outpatient procedure leaves minimal scarring at the puncture site and can be either the primary treatment or an adjunct treatment using the ClosureFast™ radiofrequency ablation catheter.
This is an image of the ClosureFast™ endovenous radiofrequency ablation stylet.

ClosureFast™ radiofrequency generator

  • The ClosureRFG™ generator delivers radiofrequency energy to the ClosureFast™ radiofrequency ablation catheter and the ClosureRFS™ radiofrequency stylet for the effective treatment of CVI.
  • The controlled feedback mechanism monitors intravascular heat parameters in real time to automatically regulate therapeutic power.
This is an image of the ClosureFast™ endovenous radiofrequency ablation generator.

Adverse events may include hematoma, phlebitis, skin injury, nerve injury, thrombophlebitis, thrombosis, and/or pulmonary embolism.


Frequently asked questions

The ClosureFast™ RFA system is a medical device used to treat superficial venous reflux. It consists of the ClosureFast™ catheter and ClosureRFG™ radiofrequency generator. The catheter delivers thermal energy via radiofrequency heating to shrink and collapse the target vein, creating a fibrotic seal and occluding the vessel.


The ClosureFast™ procedure demonstrates a 91.9% closure rate at five years, with long-term clinical data supporting its safety and efficacy.1 It provides lasting vein closure through uniform heat delivery, with a 94.9% reflux-free rate at five years.1


The ClosureFast™ system is designed for use with the ClosureRFG™ generator, model RFG3. ClosureFast™ catheters are available in 6F and 7F with 3 heating lengths, 8 cm for the 6F catheter and 3 cm or 7 cm for the 7F catheter. The ClosureRFS™ stylet, is also available for the treatment of incompetent perforator and tributary veins. See the ordering information table for more details.


The ClosureFast™ RFA system is considered safe, with over 3 million patients treated worldwide and a 91.9% closure rate at five years.1,5 Potential complications include, but are not limited to, the following: adjacent nerve injury, hematoma, pulmonary embolism, thrombosis, infection, phlebitis, skin burn or discoloration, and vessel perforation.


The ClosureFast™ procedure is contraindicated for patients with thrombus in the target vein segment. Potential complications include, but are not limited to, the following: adjacent nerve injury, hematoma, pulmonary embolism, thrombosis, infection, phlebitis, skin burn or discoloration, and vessel perforation.


ClosureFast™ radiofrequency ablation (RFA) and endovenous laser ablation (EVLA) differ in several aspects. The ClosureFast™ procedure delivers thermal energy in consistent 20-second segmental intervals, reducing variability and ensuring reliable occlusions. EVLA may experience inconsistencies due to variable pullback speeds, potentially leading to higher complication or recurrence rates. The ClosureFast™ procedure is associated with fewer complications, less postoperative pain, and lower clinical recurrence rates at five years compared to EVLA. Additionally, the ClosureFast™ procedure requires less specialist safety equipment and offers a more comfortable procedure with less bruising.1,2


Ordering information

ClosureFast™ system catheter

Item number CF6-8-60 CF6-8-100 CF7-3-60 CF7-7-60 CF7-7-100
Introducer sheath (min. ID size) 6 Fr (2.0 mm) 6 Fr (2.0 mm) 7 Fr (2.3 mm) 7 Fr (2.3 mm) 7 Fr (2.3 mm)
Insertable length (cm) 60 100 60 60 100
Heating element diameter (mm) 2.0 2.0 2.3 2.3 2.3
Heating element length (cm) 8 8 3 7 7
Maximum power setting (W) 40 40 18 40 40
Default target temperature setting (C) 120 120 120 120 120
Software version: RFG2 4.0.0 or higher 4.0.0 or higher 4.4.0 or higher 4.0.0 or higher 4.0.0 or higher
Software version: RFG3 1.11.0 or higher 1.11.0 or higher 1.11.0 or higher 1.11.0 or higher 1.11.0 or higher
Compatible guidewire (in) 0.025 0.025 0.025 0.025 0.025

 

ClosureRFG™ generator

Item number Voltage Height (cm / in) Width (cm / in) Depth (cm / in) Weight (kg / lbs.)
RFG3 Universal — 100-240 V 26.7 / 10.5 34 / 13.4 17.3 / 6.8 6.8 / 15 maximum

 

ClosureFast™ system accessories

Item number Description
CFP Procedure pack — scalpel, surgical marking pen, probe cover, table cover, plastic clamp towel, custom label, sharps block, skin closure strip, gowns, dry sponge sticks, bowls, drapes, table cover tapes, needles, and more
MIS-7F07 Micro introducer sheath set — 7 Fr x 7 cm, 21 ga TW needle, guidewire: 0.018 in x 45 cm, single-ended: straight
MIS-7F11 Micro introducer sheath set — 7 Fr x 11 cm, 21 ga TW needle, guidewire: 0.018 in x 45 cm, single-ended: straight
MIS-6F07 Micro introducer sheath set — 6 Fr x 7 cm, 21 ga TW needle, guidewire: 0.018 in, 45 cm, single-ended: straight
MIS-6F11 Micro introducer sheath set — 6 Fr x 11 cm, 21 ga x TW needle, guidewire: 0.018 in, 45 cm, single-ended: straight
IS-7F07 Introducer sheath set — 7 Fr x 7 cm, 19 ga UTW needle, guidewire: 0.035 in x 45 cm, J / straight double-ended
IS-7F11 Introducer sheath set — 7 Fr x 11 cm, 19 ga UTW needle, guidewire: 0.035 in x 45 cm, J / straight double-ended
MPK-4F Micro puncture kit — 4 Fr, 21 ga TW needle, guidewire: 0.018 in x 45 cm, single-ended: straight
MPK-5F Micro puncture kit — 5 Fr, 21 ga TW needle, guidewire: 0.018 in x 45 cm, single-ended: straight
AN-19G Percutaneous entry needle — 19 ga, length: 2.75 in, UTW
AN-19GE Percutaneous entry needle — 19 ga, length: 2.75 in, UTW echogenic tip
AN-21G Percutaneous entry needle — 21 ga, length: 2.75 in, TW
AN-21GE Percutaneous entry needle — 21 ga, length: 2.75 in, TW echogenic tip
GW-018-45-SS Guidewire — diameter: 0.018 in, length: 45 cm, single-ended: straight, fixed core, PTFE coated
GW-025-150-DE1.5J Guidewire — diameter: 0.025 in, length: 150 cm, double-ended: 1.5 mm J and straight, fixed core, PTFE coated
GW-025-260-1.5J Guidewire — diameter: 0.025 in, length: 260 cm, single-ended: 1.5 mm J, fixed core, PTFE coated
GW-035-45 Guidewire — diameter: 0.035 in, length: 45 cm, double-ended: 3 mm J and straight, fixed core, PTFE coated
PC-6X96 Ultrasound probe cover
KIP-II Tumescent infiltration pump
TIK-01 Tumescent infiltration kit — 12 mL syringe, 108 in tube length
TTUB-4 Tumescent infiltration pump tubing set — tube length: 4 M

 

TM* Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

  1. Proebstle TM, Alm BJ, Göckeritz O, et al. Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous veins. Br J Surg. 2015;102(3):212–218. doi:10.1002/bjs.9679.
  2. Almeida JI, Kaufman J, Göckeritz O, et al. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: A multicenter, single-blinded, randomized study (RECOVERY Study). J Vasc Interv Radiol. 2009;20(6):752–759. doi:10.1016/j.jvir.2009.03.008.
  3. ClosureFast™ and ClosureFast™ RFS patents. Medtronic data on file, 2022.
  4. Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2020;8(6):978–989. doi:10.1016/j.jvsv.2019.12.080.
  5. ClosureFast™ procedures. Medtronic data on file, 2024.
  6. Medtronic ClosureFast™ procedure publications. Medtronic data on file, 2022.